VERO Biotech
PrivateLast Round
Debt
Feb 7, 2024
Total Funding Raised
$230.7M
Company Overview
VERO Biotech is a biotechnology company that designs, develops, and commercializes inhaled nitric oxide delivery systems for the treatment of pulmonary and cardiac diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VERO Biotech Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
VERO Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Feb 7, 2024 | ||||
| VC Round | Jan 11, 2023 | ||||
| Series E | Dec 15, 2021 | ||||
| Debt | Jan 12, 2021 | ||||
| Grant | Aug 15, 2011 |
VERO Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Runway Growth Capital | Debt |
| National Institute of Allergy and Infectious Diseases | Grant |
| Monroe Capital | Debt |
| U.S. Department of Health and Human Services | Grant |
| Petrichor Healthcare Capital Management | VC Round |
| Horizon Technology Finance Corporation | Debt |
| MVM Life Science Partners LLP | Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 7, 2024
Raised $65M Debt round
- Dec 15, 2021
Raised $100M Series E round
VERO Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VERO Biotech's valuation, stock price, and market status.